Reduced Frontal White Matter Volume in Long-Term Childhood Leukemia Survivors: A Voxel-Based Morphometry Study

BACKGROUND AND PURPOSE: To our knowledge, no published studies have examined whole-brain regional differences to identify more discrete volumetric changes in the brains of childhood leukemia survivors. We used voxel-based morphometry (VBM) to examine regional gray and white matter differences in a group of long-term survivors of acute lymphoblastic leukemia (ALL) compared with a group of healthy controls. Differences in regional white matter volume were expected, given previous reports of white matter changes during treatment for ALL and reduced brain white matter volumes in long-term survivors. Follow-up analyses examined the relationship of regional brain volumes to cognitive function. MATERIALS AND METHODS: We compared 9 long-term survivors of ALL with 14 healthy controls. Survivors of ALL were treated with systemic and intrathecal chemotherapy only. T1-weighted axial 3D spoiled gradient high-resolution images collected on a 1.5T MR imaging scanner were used for the VBM analysis. Neuropsychological evaluations were conducted within 2 months of the MR imaging to assess cognitive function. RESULTS: VBM analysis revealed 2 specific regions of reduced white matter in the right frontal lobes of survivors of ALL compared with healthy controls. Survivors of ALL had lower performances on tests of attention, visual-constructional skills, mental flexibility, and math achievement compared with healthy individuals. Decreased performance on neuropsychological measures was associated with decreased regional white matter volumes. No differences were found between the groups with respect to gray matter regions. CONCLUSION: These findings are consistent with previous literature describing the long-term cognitive, academic, and imaging findings of survivors of ALL and suggest that right frontal white matter is particularly vulnerable to disruption following intensive chemotherapy for ALL. Future studies should focus on further clarifying the white matter changes observed.

[1]  J. Grafman,et al.  The calculating brain: an fMRI study , 2000, Neuropsychologia.

[2]  L. Ries,et al.  Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. , 1999, Journal of the National Cancer Institute.

[3]  Amar Gajjar,et al.  Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors , 2003, Cancer.

[4]  K. Kucian,et al.  Impaired neural networks for approximate calculation in dyscalculic children: a functional MRI study , 2006, Behavioral and Brain Functions.

[5]  B. Rourke Syndrome of nonverbal learning disabilities : neurodevelopmental manifestations , 2006 .

[6]  Rex E. Jung,et al.  Structural brain variation and general intelligence , 2004, NeuroImage.

[7]  Paul G. Lesnik,et al.  Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model. , 1998, Archives of neurology.

[8]  Ron Dumont,et al.  Woodcock‐Johnson III Tests of Achievement , 2008 .

[9]  A. Kingma,et al.  Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. , 2001, The Journal of pediatrics.

[10]  V. Anderson,et al.  Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors. , 1997, Pediatric rehabilitation.

[11]  E. Pääkkö,et al.  Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia , 1996, Neuroradiology.

[12]  R. Dean,et al.  TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit) , 2006 .

[13]  Ronald T. Brown,et al.  Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. , 1998, Journal of pediatric psychology.

[14]  Jewel Swanson The Delis-Kaplan Executive Function System , 2005 .

[15]  M. Finegold,et al.  Principles and practice of pediatric oncology , 2006 .

[16]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[17]  B. M. Lanning,et al.  A longitudinal magnetic resonance imaging study of the brain in survivors of childhood acute lymphoblastic leukemia , 1998, Cancer.

[18]  J. R. Prince,et al.  Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. , 1991, Radiology.

[19]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .

[20]  R. Leiguarda,et al.  Neuropsychological study in patients with ALL. Two different CNS prevention therapies--cranial irradiation plus IT methotrexate vs. IT methotrexate alone. , 1983, The American journal of pediatric hematology/oncology.

[21]  E. J. Carter,et al.  Functional Imaging of Numerical Processing in Adults and 4-y-Old Children , 2006, PLoS biology.

[22]  Winnie C W Chu,et al.  White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy. , 2003, Radiology.

[23]  J. Kramer,et al.  Cognitive consequences and central nervous system injury following treatment for childhood leukemia. , 2000, Seminars in oncology nursing.

[24]  S. Woo,et al.  Prevention and treatment of meningeal leukemia in children. , 1994, Blood.

[25]  C. Pui,et al.  Smaller white‐matter volumes are associated with larger deficits in attention and learning among long‐term survivors of acute lymphoblastic leukemia , 2006, Cancer.

[26]  M Wilke,et al.  Normative pediatric brain data for spatial normalization and segmentation differs from standard adult data , 2003, Magnetic resonance in medicine.

[27]  Yukio Miki,et al.  Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate , 1992, Cancer.

[28]  R. Mulhern,et al.  Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Francis,et al.  Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K. Kaemingk,et al.  Math Weaknesses in Survivors of Acute Lymphoblastic Leukemia Compared to Healthy Children , 2004, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[31]  R. Riccardi,et al.  Long‐term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia , 2002, Cancer.

[32]  G. Tripp,et al.  Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. , 2000, Journal of pediatric psychology.

[33]  N. Tarbell,et al.  Toxicity of CNS prophylaxis for childhood leukemia. , 1997, Oncology.

[34]  J. Kramer,et al.  Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. , 2001, Journal of pediatric psychology.

[35]  K. Krull,et al.  Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. , 2006, Journal of pediatric psychology.

[36]  G. Schroth,et al.  Pure methotrexate encephalopathy presenting with seizures: CT and MRI features , 1998, Pediatric Radiology.

[37]  K. Ciesielski,et al.  Visual and verbal short-term memory deficits in childhood leukemia survivors after intrathecal chemotherapy. , 1997, Journal of pediatric psychology.

[38]  A. Reiss,et al.  Brain development, gender and IQ in children. A volumetric imaging study. , 1996, Brain : a journal of neurology.

[39]  L. Bérubé,et al.  [Clinical neuropsychology]. , 1982, Nursing Quebec.

[40]  E. Pääkkö,et al.  White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. , 2000, Medical and pediatric oncology.

[41]  Stephen Ashwal,et al.  Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research , 1998, Pediatric Research.

[42]  David Wechsler,et al.  Manual for the Wechsler intelligence scale for children , 1974 .

[43]  J. Dubé,et al.  Computed tomography brain scans in long term survivors of childhood acute lymphoblastic leukemia. , 1981, Medical and pediatric oncology.

[44]  M. Skalej,et al.  CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. , 1997, Medical and pediatric oncology.

[45]  J. Giedd,et al.  Brain development in children and adolescents: Insights from anatomical magnetic resonance imaging , 2006, Neuroscience & Biobehavioral Reviews.

[46]  Barbara J. Wendling,et al.  Woodcock-Johnson III Tests of Achievement. , 2009 .

[47]  F. Balis,et al.  Central nervous system pharmacology of antileukemic drugs. , 1989, The American journal of pediatric hematology/oncology.

[48]  M. Sawyer,et al.  A 3-Year Follow-Up of the Intellectual and Academic Functioning of Children Receiving Central Nervous System Prophylactic Chemotherapy for Leukemia , 1996, Journal of developmental and behavioral pediatrics : JDBP.

[49]  W. Bowman,et al.  Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  R. Vergés,et al.  Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens. , 1992, International journal of radiation oncology, biology, physics.

[51]  B. Moore Neurocognitive outcomes in survivors of childhood cancer. , 2005, Journal of pediatric psychology.

[52]  M. Sawyer,et al.  Longitudinal follow-up of the intellectual and academic functioning of children receiving central nervous system-prophylactic chemotherapy for leukemia: a four-year final report. , 1999, Journal of developmental and behavioral pediatrics : JDBP.

[53]  J. M. Britton,et al.  Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer. , 2000, Medical and pediatric oncology.